166 related articles for article (PubMed ID: 27920129)
1. Chronic Inhibition of Renal Outer Medullary Potassium Channel Not Only Prevented but Also Reversed Development of Hypertension and End-Organ Damage in Dahl Salt-Sensitive Rats.
Zhou X; Forrest MJ; Sharif-Rodriguez W; Forrest G; Szeto D; Urosevic-Price O; Zhu Y; Stevenson AS; Zhou Y; Stribling S; Dajee M; Walsh SP; Pasternak A; Sullivan KA
Hypertension; 2017 Feb; 69(2):332-338. PubMed ID: 27920129
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous disruption of renal outer medullary potassium channel in rats is associated with reduced blood pressure.
Zhou X; Zhang Z; Shin MK; Horwitz SB; Levorse JM; Zhu L; Sharif-Rodriguez W; Streltsov DY; Dajee M; Hernandez M; Pan Y; Urosevic-Price O; Wang L; Forrest G; Szeto D; Zhu Y; Cui Y; Michael B; Balogh LA; Welling PA; Wade JB; Roy S; Sullivan KA
Hypertension; 2013 Aug; 62(2):288-94. PubMed ID: 23753405
[TBL] [Abstract][Full Text] [Related]
3. Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys.
Hoagland KM; Flasch AK; Dahly-Vernon AJ; dos Santos EA; Knepper MA; Roman RJ
Hypertension; 2004 Apr; 43(4):860-5. PubMed ID: 14967839
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ROMK blocks macula densa tubuloglomerular feedback yet causes renal vasoconstriction in anesthetized rats.
Araujo M; Welch WJ; Zhou X; Sullivan K; Walsh S; Pasternak A; Wilcox CS
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1120-F1127. PubMed ID: 28228405
[TBL] [Abstract][Full Text] [Related]
5. K
Zietara A; Palygin O; Levchenko V; Dissanayake LV; Klemens CA; Geurts A; Denton JS; Staruschenko A
Am J Physiol Renal Physiol; 2023 Aug; 325(2):F177-F187. PubMed ID: 37318990
[TBL] [Abstract][Full Text] [Related]
6. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.
Hampton C; Zhou X; Priest BT; Pai LY; Felix JP; Thomas-Fowlkes B; Liu J; Kohler M; Xiao J; Corona A; Price O; Gill C; Shah K; Rasa C; Tong V; Owens K; Ormes J; Tang H; Roy S; Sullivan KA; Metzger JM; Alonso-Galicia M; Kaczorowski GJ; Pasternak A; Garcia ML
J Pharmacol Exp Ther; 2016 Oct; 359(1):194-206. PubMed ID: 27432892
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
Tian N; Thrasher KD; Gundy PD; Hughson MD; Manning RD
Hypertension; 2005 May; 45(5):934-9. PubMed ID: 15837840
[TBL] [Abstract][Full Text] [Related]
8. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
[TBL] [Abstract][Full Text] [Related]
9. Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats.
Miyata N; Cowley AW
Hypertension; 1999 Jan; 33(1 Pt 2):446-50. PubMed ID: 9931145
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.
Garcia ML; Priest BT; Alonso-Galicia M; Zhou X; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Liu J; Swensen A; Pai LY; Xiao J; Hernandez M; Hoagland K; Owens K; Tang H; de Jesus RK; Roy S; Kaczorowski GJ; Pasternak A
J Pharmacol Exp Ther; 2014 Jan; 348(1):153-64. PubMed ID: 24142912
[TBL] [Abstract][Full Text] [Related]
11. Renal medullary interstitial infusion of L-arginine prevents hypertension in Dahl salt-sensitive rats.
Miyata N; Zou AP; Mattson DL; Cowley AW
Am J Physiol; 1998 Nov; 275(5):R1667-73. PubMed ID: 9791089
[TBL] [Abstract][Full Text] [Related]
12. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
Tian N; Rose RA; Jordan S; Dwyer TM; Hughson MD; Manning RD
J Hypertens; 2006 Nov; 24(11):2263-70. PubMed ID: 17053549
[TBL] [Abstract][Full Text] [Related]
13. Aberrant ENaC activation in Dahl salt-sensitive rats.
Kakizoe Y; Kitamura K; Ko T; Wakida N; Maekawa A; Miyoshi T; Shiraishi N; Adachi M; Zhang Z; Masilamani S; Tomita K
J Hypertens; 2009 Aug; 27(8):1679-89. PubMed ID: 19458538
[TBL] [Abstract][Full Text] [Related]
14. Alpha1 Na,K-ATPase and Na,K,2Cl-cotransporte/D3mit3 loci interact to increase susceptibility to salt-sensitive hypertension in Dahl S(HSD) rats.
Herrera VL; Lopez LV; Ruiz-Opazo N
Mol Med; 2001 Feb; 7(2):125-34. PubMed ID: 11471547
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics.
Aretz CD; Vadukoot AK; Hopkins CR
J Med Chem; 2019 Oct; 62(19):8682-8694. PubMed ID: 31034224
[TBL] [Abstract][Full Text] [Related]
16. Differential Effect of Renal Cortical and Medullary Interstitial Fluid Calcium on Blood Pressure Regulation in Salt-Sensitive Hypertension.
Pointer MA; Eley S; Anderson L; Waters B; Royall B; Nichols S; Wells C
Am J Hypertens; 2015 Aug; 28(8):1049-55. PubMed ID: 25552516
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic response to renal medullary endothelin B receptor activation is impaired in Dahl-salt sensitive rats on a high-fat diet.
Kittikulsuth W; Hyndman KA; Pollock JS; Pollock DM
Physiol Res; 2018 Jun; 67(Suppl 1):S149-S154. PubMed ID: 29947535
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats.
Kumar V; Evans LC; Kurth T; Yang C; Wollner C; Nasci V; Zheleznova NN; Bukowy J; Dayton A; Cowley AW
Hypertension; 2019 Mar; 73(3):630-639. PubMed ID: 30595123
[TBL] [Abstract][Full Text] [Related]
19. Essential role of Kir5.1 channels in renal salt handling and blood pressure control.
Palygin O; Levchenko V; Ilatovskaya DV; Pavlov TS; Pochynyuk OM; Jacob HJ; Geurts AM; Hodges MR; Staruschenko A
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931751
[TBL] [Abstract][Full Text] [Related]
20. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
Bhave G; Chauder BA; Liu W; Dawson ES; Kadakia R; Nguyen TT; Lewis LM; Meiler J; Weaver CD; Satlin LM; Lindsley CW; Denton JS
Mol Pharmacol; 2011 Jan; 79(1):42-50. PubMed ID: 20926757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
